| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/24/2007 | US7247619 Modulate immunology response; isolation nucleic acids; induce immunology response; genetic engineering |
| 07/24/2007 | US7247618 Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling |
| 07/24/2007 | US7247615 Nucleic acid encoding peptides which antagonist epitope against prostate specific antigen; anticancer agents |
| 07/24/2007 | US7247480 Aggregations; for use in the treatment of autoimune diseases; for use in immunotherapy |
| 07/24/2007 | US7247479 Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease |
| 07/24/2007 | US7247472 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 07/24/2007 | US7247447 Methods to obtain and use such proteins, antibodies, and inhibitory compounds; treating flea infestations in animals; biological pest control |
| 07/24/2007 | US7247436 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 07/24/2007 | US7247431 Human source leading sequence, gene vector and gene expression strategy |
| 07/24/2007 | US7247305 Amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 07/24/2007 | US7247298 Administering pluripotent cells |
| 07/24/2007 | US7247297 Use of DF3/MUC1 regulated expression in gene therapy |
| 07/24/2007 | CA2328404C Novel lentiviral packaging cells |
| 07/24/2007 | CA2097185C Viral recombinant vectors for expression in muscle cells |
| 07/19/2007 | WO2007081982A2 Methods and compositions for mediation of immune responses and adjuvant activity |
| 07/19/2007 | WO2007081848A2 Activation of hcv-specific t cells |
| 07/19/2007 | WO2007080902A1 Composition inhibiting the expression of target gene in eyeball and remedy for disease in eyeball |
| 07/19/2007 | WO2007079753A2 Mutant deoxyadenosine kinase enzymes and their use |
| 07/19/2007 | WO2007063545A3 Methods of improving stem cell homing and engraftment |
| 07/19/2007 | WO2005121377A3 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase |
| 07/19/2007 | WO2005072057A3 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 07/19/2007 | WO2003054144A8 Human ras interacting protein |
| 07/19/2007 | WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 07/19/2007 | US20070169207 Transgenic nonhuman animal having germ or somatic cell containing nucleic acid encoding human amyloid precursor protein including nucleotides encoding codon 670 and 671; diagnosing and/or predicting predisposition; drug screening |
| 07/19/2007 | US20070167394 Methods and compositions for diagnosing and suppressing metastasis thereof |
| 07/19/2007 | US20070167393 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/19/2007 | US20070167392 Nucleosides; RNA interference; gene expression inhibition; for use in therapeutic, diagnostic, and research applications involving gene silencing |
| 07/19/2007 | US20070167391 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 07/19/2007 | US20070167390 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 07/19/2007 | US20070167389 Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 07/19/2007 | US20070167388 Nucleotide sequences promoting the trans-membrane transport of nucleic acids |
| 07/19/2007 | US20070167387 nucleosides or oligonucleotide analogues having excellent enzyme resistance and potent selective binding affinity for single-stranded RNA, and excellent triplex-forming capacity with double-stranded DNA |
| 07/19/2007 | US20070167386 Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the same |
| 07/19/2007 | US20070167385 for treatment of chronic inflammatory bowel disease, Crohn's disease and ulcerative colitis |
| 07/19/2007 | US20070167384 Modified polynucleotides for use in rna interference |
| 07/19/2007 | US20070166824 Manipulation of non-terminally differentiated cells using the notch pathway |
| 07/19/2007 | US20070166788 Methods for production of receptor and ligand isoforms |
| 07/19/2007 | US20070166734 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 07/19/2007 | US20070166717 Methods and materials for assessing prostate cancer therapies |
| 07/19/2007 | US20070166711 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof |
| 07/19/2007 | US20070166710 Methods for inhibiting adipogenesis and for treating type 2 diabetes |
| 07/19/2007 | US20070166701 Methods for detecting flavivirus infection |
| 07/19/2007 | US20070166696 Adenovirus-transfected primary cells and methods of pathway mapping |
| 07/19/2007 | US20070166367 Adept or gdept producing acetaldehyde |
| 07/19/2007 | US20070166366 Autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells |
| 07/19/2007 | US20070166359 HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing |
| 07/19/2007 | US20070166335 Allergy inhibitor compositions and kits and methods of using the same |
| 07/19/2007 | US20070166330 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 07/19/2007 | US20070166329 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 07/19/2007 | US20070166328 Genetic immunization against cervical carcinoma |
| 07/19/2007 | US20070166327 Express chimeric anti-tumor receptors; cancer and autoimmune diseases eg lupus or rheumatoid arthritis |
| 07/19/2007 | US20070166318 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| 07/19/2007 | US20070166314 EpA2 monoclonal antibodies and methods of use thereof |
| 07/19/2007 | US20070166312 Antibody against tumor specific antigen as target |
| 07/19/2007 | US20070166296 Therapeutic Systems |
| 07/19/2007 | US20070166293 Supporting cell differentiation in culture with a genetical modified cells; use for gene therapy; supporters being genetically modified in order to provide externally regulatable interactions between the supporters and the stem cells; supporters and stem cells are interchangeable upon modification |
| 07/19/2007 | US20070166292 Effectively delivering therapeutic agents to target tissues via reperfusion of fluids; reducing ischemic injury in transplanted tissues |
| 07/19/2007 | US20070166291 Cell preparation |
| 07/19/2007 | US20070166287 Oncolytic virus |
| 07/19/2007 | US20070166286 Self-rearranging DNA vectors |
| 07/19/2007 | US20070166285 Systems and methods related to degradation of uremic toxins |
| 07/19/2007 | US20070166284 Therapeutic regimen for treating cancer |
| 07/19/2007 | US20070166283 Compositions and methods for the treatment of hemophilia a |
| 07/18/2007 | EP1808488A2 DNA sequences having anti-repressor activity |
| 07/18/2007 | EP1808182A1 Lim mineralization protein splice variants |
| 07/18/2007 | EP1808180A2 Modified GP 100 and uses thereof |
| 07/18/2007 | EP1808161A1 Microprojectile delivery system and particulate product |
| 07/18/2007 | EP1808160A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/18/2007 | EP1807514A1 Therapeutic rnai agents for treating psoriasis |
| 07/18/2007 | EP1807157A2 Use of apoptosis inhibiting compounds in degenerative neurological disorders |
| 07/18/2007 | EP1807117A2 Compositions and methods for treating cancer using compositions comprising an inhibitor of endothelin receptor activity |
| 07/18/2007 | EP1807116A2 Influenza vaccination |
| 07/18/2007 | EP1807110A2 Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter |
| 07/18/2007 | EP1497436B1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolic disorders using such raav virons |
| 07/18/2007 | EP1285002B1 Regulating lipid levels via the zmax1 or hbm gene |
| 07/18/2007 | EP1186667B1 Envelope gene-deficient virus vector of paramyxoviridae |
| 07/18/2007 | EP1088077B1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 07/18/2007 | EP1076715B1 Lentiviral packaging cells |
| 07/18/2007 | EP0840623B1 Compositions for gene therapy comprising nucleic acid loaded polymeric microparticles |
| 07/18/2007 | EP0770140B1 Composition containing nucleic acids and cationic polymers, preparation and uses |
| 07/18/2007 | CN1326880C G-CSF receptor agonist antibodies and screening method therefor |
| 07/18/2007 | CN1326876C Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/18/2007 | CN1326873C Vaccine for the prophylactic or therapeutic immunization against HIV |
| 07/18/2007 | CN1326562C Use of IL-18 inhibitors for treatment and/or prevention of heart disease |
| 07/18/2007 | CN101001948A Procollagen IIA deficient mice |
| 07/18/2007 | CN101001646A Stabilized synthetic immunogen delivery system |
| 07/18/2007 | CN101001615A Drug delivery product and methods |
| 07/18/2007 | CN100999734A Application in adenovirus expression carrier of humen immunoglobulin storter |
| 07/18/2007 | CN100998874A IIIV vaccine containing recombination virus and its united immune preparation |
| 07/18/2007 | CN100998873A Gone medicine for preventing and treating mammitis of animal |
| 07/17/2007 | US7244827 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| 07/17/2007 | US7244818 Interferon alpha responsive protein |
| 07/17/2007 | US7244715 Vaccines containing ribavirin and methods of use thereof |
| 07/17/2007 | US7244704 Exploiting endogenous import and export mechanisms of ribonucleic acid trafficking which utilize nuclear targeting peptides containing nonclassical nuclear localization signals |
| 07/17/2007 | US7244617 Generating transgenic cell comprising expression vector coding apotosis inducing factor for use in treatment of cell proliferative and viral disorders |
| 07/17/2007 | US7244613 Expression vector comprising nucleotide sequences coding tubercular complex for use in developing vaccines for treatment and prevention of respiratory system disorders; bactericides |
| 07/17/2007 | US7244577 Method of screening for modulator of LRP5 activity |
| 07/17/2007 | US7244437 Clostridial toxin derivatives and methods for treating pain |
| 07/17/2007 | US7244436 Clostridial toxin derivatives and methods for treating pain |
| 07/17/2007 | US7244435 DNA vaccine expressing HA1 of equine-2 influenza virus |